 | • レポートコード：MRC2102QY0947 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の喘息治療薬市場について種類別（クイックリリーフ薬、長期管理用薬、妊娠中喘息薬）、用途別（子供、青年、大人）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・喘息治療薬市場の概要 ・世界の主要地域別喘息治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の喘息治療薬市場規模2015-2026：種類別（クイックリリーフ薬、長期管理用薬、妊娠中喘息薬） ・世界の喘息治療薬市場規模2015-2026：用途別（子供、青年、大人） ・喘息治療薬の米国市場規模2015-2020 ・喘息治療薬のヨーロッパ市場規模2015-2020 ・喘息治療薬の中国市場規模2015-2020 ・喘息治療薬の日本市場規模2015-2020 ・喘息治療薬の東南アジア市場規模2015-2020 ・喘息治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・喘息治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・喘息治療薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Asthma Medication Market
The global Asthma Medication market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Asthma Medication Scope and Market Size
The global Asthma Medication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Asthma Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Asthma Medication market is segmented into
Quick-Relief Medications
Long-Term Control Medications
Asthma Medications During Pregnancy
Segment by Application, the Asthma Medication market is segmented into
Children
Adolescent
Adult
The Asthma Medication market is analysed and market size information is provided by regions (countries). Segment by Application, the Asthma Medication market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Asthma Medication Market Share Analysis
Asthma Medication market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Asthma Medication business, the date to enter into the Asthma Medication market, Asthma Medication product introduction, recent developments, etc.
The major vendors covered:
Dulera
QVAR
Glaxosmithkline plc
MAP Pharmaceuticals，Inc
Merck & Co. Inc
AstraZeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi-Aventis
Theravance Inc
1 Asthma Medication Market Overview
1.1 Asthma Medication Product Scope
1.2 Asthma Medication Segment by Type
1.2.1 Global Asthma Medication Sales by Type (2020-2026)
1.2.2 Quick-Relief Medications
1.2.3 Long-Term Control Medications
1.2.4 Asthma Medications During Pregnancy
1.3 Asthma Medication Segment by Application
1.3.1 Global Asthma Medication Sales Comparison by Application (2020-2026)
1.3.2 Children
1.3.3 Adolescent
1.3.4 Adult
1.4 Asthma Medication Market Estimates and Forecasts (2015-2026)
1.4.1 Global Asthma Medication Sales Growth Rate (2015-2026)
1.4.2 Global Asthma Medication Revenue and Growth Rate (2015-2026)
1.4.3 Global Asthma Medication Price Trends (2015-2026)
2 Asthma Medication Estimate and Forecast by Region
2.1 Global Asthma Medication Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Asthma Medication Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Asthma Medication Sales Market Share by Region (2015-2020)
2.2.2 Global Asthma Medication Revenue Market Share by Region (2015-2020)
2.3 Global Asthma Medication Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Asthma Medication Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Asthma Medication Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Asthma Medication Estimates and Projections (2015-2026)
2.4.2 Europe Asthma Medication Estimates and Projections (2015-2026)
2.4.3 China Asthma Medication Estimates and Projections (2015-2026)
2.4.4 Japan Asthma Medication Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Asthma Medication Estimates and Projections (2015-2026)
2.4.6 India Asthma Medication Estimates and Projections (2015-2026)
3 Global Asthma Medication Competition Landscape by Players
3.1 Global Top Asthma Medication Players by Sales (2015-2020)
3.2 Global Top Asthma Medication Players by Revenue (2015-2020)
3.3 Global Asthma Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Medication as of 2019)
3.4 Global Asthma Medication Average Price by Company (2015-2020)
3.5 Manufacturers Asthma Medication Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Asthma Medication Players (Opinion Leaders)
4 Global Asthma Medication Market Size by Type
4.1 Global Asthma Medication Historic Market Review by Type (2015-2020)
4.1.1 Global Asthma Medication Sales Market Share by Type (2015-2020)
4.1.2 Global Asthma Medication Revenue Market Share by Type (2015-2020)
4.1.3 Global Asthma Medication Price by Type (2015-2020)
4.2 Global Asthma Medication Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Asthma Medication Sales Forecast by Type (2021-2026)
4.2.2 Global Asthma Medication Revenue Forecast by Type (2021-2026)
4.2.3 Global Asthma Medication Price Forecast by Type (2021-2026)
5 Global Asthma Medication Market Size by Application
5.1 Global Asthma Medication Historic Market Review by Application (2015-2020)
5.1.1 Global Asthma Medication Sales Market Share by Application (2015-2020)
5.1.2 Global Asthma Medication Revenue Market Share by Application (2015-2020)
5.1.3 Global Asthma Medication Price by Application (2015-2020)
5.2 Global Asthma Medication Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Asthma Medication Sales Forecast by Application (2021-2026)
5.2.2 Global Asthma Medication Revenue Forecast by Application (2021-2026)
5.2.3 Global Asthma Medication Price Forecast by Application (2021-2026)
6 United States Asthma Medication Market Facts & Figures
6.1 United States Asthma Medication Sales Market Share by Company (2015-2020)
6.2 United States Asthma Medication Sales Market Share by Type (2015-2020)
6.3 United States Asthma Medication Sales Market Share by Application (2015-2020)
7 Europe Asthma Medication Market Facts & Figures
7.1 Europe Asthma Medication Sales Market Share by Company (2015-2020)
7.2 Europe Asthma Medication Sales Market Share by Type (2015-2020)
7.3 Europe Asthma Medication Sales Market Share by Application (2015-2020)
8 China Asthma Medication Market Facts & Figures
8.1 China Asthma Medication Sales Market Share by Company (2015-2020)
8.2 China Asthma Medication Sales Market Share by Type (2015-2020)
8.3 China Asthma Medication Sales Market Share by Application (2015-2020)
9 Japan Asthma Medication Market Facts & Figures
9.1 Japan Asthma Medication Sales Market Share by Company (3015-3030)
9.2 Japan Asthma Medication Sales Market Share by Type (2015-2020)
9.3 Japan Asthma Medication Sales Market Share by Application (2015-2020)
10 Southeast Asia Asthma Medication Market Facts & Figures
10.1 Southeast Asia Asthma Medication Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Asthma Medication Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Asthma Medication Sales Market Share by Application (2015-2020)
11 India Asthma Medication Market Facts & Figures
11.1 India Asthma Medication Sales Market Share by Company (2015-2020)
11.2 India Asthma Medication Sales Market Share by Type (2015-2020)
11.3 India Asthma Medication Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Asthma Medication Business
12.1 Dulera
12.1.1 Dulera Corporation Information
12.1.2 Dulera Business Overview
12.1.3 Dulera Asthma Medication Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Dulera Asthma Medication Products Offered
12.1.5 Dulera Recent Development
12.2 QVAR
12.2.1 QVAR Corporation Information
12.2.2 QVAR Business Overview
12.2.3 QVAR Asthma Medication Sales, Revenue and Gross Margin (2015-2020)
12.2.4 QVAR Asthma Medication Products Offered
12.2.5 QVAR Recent Development
12.3 Glaxosmithkline plc
12.3.1 Glaxosmithkline plc Corporation Information
12.3.2 Glaxosmithkline plc Business Overview
12.3.3 Glaxosmithkline plc Asthma Medication Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Glaxosmithkline plc Asthma Medication Products Offered
12.3.5 Glaxosmithkline plc Recent Development
12.4 MAP Pharmaceuticals，Inc
12.4.1 MAP Pharmaceuticals，Inc Corporation Information
12.4.2 MAP Pharmaceuticals，Inc Business Overview
12.4.3 MAP Pharmaceuticals，Inc Asthma Medication Sales, Revenue and Gross Margin (2015-2020)
12.4.4 MAP Pharmaceuticals，Inc Asthma Medication Products Offered
12.4.5 MAP Pharmaceuticals，Inc Recent Development
12.5 Merck & Co. Inc
12.5.1 Merck & Co. Inc Corporation Information
12.5.2 Merck & Co. Inc Business Overview
12.5.3 Merck & Co. Inc Asthma Medication Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Merck & Co. Inc Asthma Medication Products Offered
12.5.5 Merck & Co. Inc Recent Development
12.6 AstraZeneca plc
12.6.1 AstraZeneca plc Corporation Information
12.6.2 AstraZeneca plc Business Overview
12.6.3 AstraZeneca plc Asthma Medication Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AstraZeneca plc Asthma Medication Products Offered
12.6.5 AstraZeneca plc Recent Development
12.7 Roche Holdings Ltd
12.7.1 Roche Holdings Ltd Corporation Information
12.7.2 Roche Holdings Ltd Business Overview
12.7.3 Roche Holdings Ltd Asthma Medication Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Roche Holdings Ltd Asthma Medication Products Offered
12.7.5 Roche Holdings Ltd Recent Development
12.8 Genentech Inc
12.8.1 Genentech Inc Corporation Information
12.8.2 Genentech Inc Business Overview
12.8.3 Genentech Inc Asthma Medication Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Genentech Inc Asthma Medication Products Offered
12.8.5 Genentech Inc Recent Development
12.9 Sepracor, Inc
12.9.1 Sepracor, Inc Corporation Information
12.9.2 Sepracor, Inc Business Overview
12.9.3 Sepracor, Inc Asthma Medication Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sepracor, Inc Asthma Medication Products Offered
12.9.5 Sepracor, Inc Recent Development
12.10 Schering-Plough Corp
12.10.1 Schering-Plough Corp Corporation Information
12.10.2 Schering-Plough Corp Business Overview
12.10.3 Schering-Plough Corp Asthma Medication Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Schering-Plough Corp Asthma Medication Products Offered
12.10.5 Schering-Plough Corp Recent Development
12.11 Sanofi-Aventis
12.11.1 Sanofi-Aventis Corporation Information
12.11.2 Sanofi-Aventis Business Overview
12.11.3 Sanofi-Aventis Asthma Medication Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sanofi-Aventis Asthma Medication Products Offered
12.11.5 Sanofi-Aventis Recent Development
12.12 Theravance Inc
12.12.1 Theravance Inc Corporation Information
12.12.2 Theravance Inc Business Overview
12.12.3 Theravance Inc Asthma Medication Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Theravance Inc Asthma Medication Products Offered
12.12.5 Theravance Inc Recent Development
13 Asthma Medication Manufacturing Cost Analysis
13.1 Asthma Medication Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Asthma Medication
13.4 Asthma Medication Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Asthma Medication Distributors List
14.3 Asthma Medication Customers
15 Market Dynamics
15.1 Asthma Medication Market Trends
15.2 Asthma Medication Opportunities and Drivers
15.3 Asthma Medication Market Challenges
15.4 Asthma Medication Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Asthma Medication Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Asthma Medication Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Asthma Medication Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Asthma Medication Sales (K Units) by Region (2015-2020)
Table 5. Global Asthma Medication Sales Market Share by Region (2015-2020)
Table 6. Global Asthma Medication Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Asthma Medication Revenue Share by Region (2015-2020)
Table 8. Global Asthma Medication Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Asthma Medication Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Asthma Medication Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Asthma Medication Revenue Share Forecast by Region (2021-2026)
Table 12. Global Asthma Medication (K Units) of Key Companies (2015-2020)
Table 13. Global Asthma Medication Sales Share by Company (2015-2020)
Table 14. Global Asthma Medication Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Asthma Medication Revenue Share by Company (2015-2020)
Table 16. Global Asthma Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Medication as of 2019)
Table 17. Global Asthma Medication Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Asthma Medication Manufacturing Sites and Area Served
Table 19. Manufacturers Asthma Medication Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Asthma Medication Players
Table 22. Global Asthma Medication Sales (K Units) by Type (2015-2020)
Table 23. Global Asthma Medication Sales Share by Type (2015-2020)
Table 24. Global Asthma Medication Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Asthma Medication Price (K Units) by Type (2015-2020)
Table 26. Global Asthma Medication Sales Share by Type (2021-2026)
Table 27. Global Asthma Medication Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Asthma Medication Revenue Share by Type (2021-2026)
Table 29. Global Asthma Medication Price (K Units) by Type (2021-2026)
Table 30. Global Asthma Medication Sales (K Units) by Application (2015-2020)
Table 31. Global Asthma Medication Sales Share by Application (2015-2020)
Table 32. Global Asthma Medication Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Asthma Medication Price (K Units) by Application (2015-2020)
Table 34. Global Asthma Medication Sales (K Units) by Application (2021-2026)
Table 35. Global Asthma Medication Sales Share by Application (2021-2026)
Table 36. Global Asthma Medication Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Asthma Medication Revenue Share by Application (2021-2026)
Table 38. Global Asthma Medication Price (K Units) by Application (2021-2026)
Table 39. United States Asthma Medication Sales (K Units) by Company (2015-2020)
Table 40. United States Asthma Medication Sales Market Share by Company (2015-2020)
Table 41. United States Asthma Medication Sales (K Units) by Type (2015-2020)
Table 42. United States Asthma Medication Sales Market Share by Type (2015-2020)
Table 43. United States Asthma Medication Sales (K Units) by Application (2015-2020)
Table 44. United States Asthma Medication Sales Market Share by Application (2015-2020)
Table 45. Europe Asthma Medication Sales (K Units) by Company (2015-2020)
Table 46. Europe Asthma Medication Sales Market Share by Company (2015-2020)
Table 47. Europe Asthma Medication Sales (K Units) by Type (2015-2020)
Table 48. Europe Asthma Medication Sales Market Share by Type (2015-2020)
Table 49. Europe Asthma Medication Sales (K Units) by Application (2015-2020)
Table 50. Europe Asthma Medication Sales Market Share by Type (2015-2020)
Table 51. China Asthma Medication Sales (K Units) by Company (2015-2020)
Table 52. China Asthma Medication Sales Market Share by Company (2015-2020)
Table 53. China Asthma Medication Sales (K Units) by Type (2015-2020)
Table 54. China Asthma Medication Sales Market Share by Type (2015-2020)
Table 55. China Asthma Medication Sales (K Units) by Application (2015-2020)
Table 56. China Asthma Medication Sales Market Share by Application (2015-2020)
Table 57. Japan Asthma Medication Sales (K Units) by Company (2015-2020)
Table 58. Japan Asthma Medication Sales Market Share by Company (2015-2020)
Table 59. Japan Asthma Medication Sales (K Units) by Type (2015-2020)
Table 60. Japan Asthma Medication Sales Market Share by Type (2015-2020)
Table 61. Japan Asthma Medication Sales (K Units) by Application (2015-2020)
Table 62. Japan Asthma Medication Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Asthma Medication Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Asthma Medication Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Asthma Medication Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Asthma Medication Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Asthma Medication Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Asthma Medication Sales Market Share by Application (2015-2020)
Table 69. India Asthma Medication Sales (K Units) by Company (2015-2020)
Table 70. India Asthma Medication Sales Market Share by Company (2015-2020)
Table 71. India Asthma Medication Sales (K Units) by Type (2015-2020)
Table 72. India Asthma Medication Sales Market Share by Type (2015-2020)
Table 73. India Asthma Medication Sales (K Units) by Application (2015-2020)
Table 74. India Asthma Medication Sales Market Share by Application (2015-2020)
Table 75. Dulera Corporation Information
Table 76. Dulera Description and Business Overview
Table 77. Dulera Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Dulera Asthma Medication Product
Table 79. Dulera Recent Development
Table 80. QVAR Corporation Information
Table 81. QVAR Description and Business Overview
Table 82. QVAR Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. QVAR Asthma Medication Product
Table 84. QVAR Recent Development
Table 85. Glaxosmithkline plc Corporation Information
Table 86. Glaxosmithkline plc Description and Business Overview
Table 87. Glaxosmithkline plc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Glaxosmithkline plc Asthma Medication Product
Table 89. Glaxosmithkline plc Recent Development
Table 90. MAP Pharmaceuticals，Inc Corporation Information
Table 91. MAP Pharmaceuticals，Inc Description and Business Overview
Table 92. MAP Pharmaceuticals，Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. MAP Pharmaceuticals，Inc Asthma Medication Product
Table 94. MAP Pharmaceuticals，Inc Recent Development
Table 95. Merck & Co. Inc Corporation Information
Table 96. Merck & Co. Inc Description and Business Overview
Table 97. Merck & Co. Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merck & Co. Inc Asthma Medication Product
Table 99. Merck & Co. Inc Recent Development
Table 100. AstraZeneca plc Corporation Information
Table 101. AstraZeneca plc Description and Business Overview
Table 102. AstraZeneca plc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. AstraZeneca plc Asthma Medication Product
Table 104. AstraZeneca plc Recent Development
Table 105. Roche Holdings Ltd Corporation Information
Table 106. Roche Holdings Ltd Description and Business Overview
Table 107. Roche Holdings Ltd Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Roche Holdings Ltd Asthma Medication Product
Table 109. Roche Holdings Ltd Recent Development
Table 110. Genentech Inc Corporation Information
Table 111. Genentech Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Genentech Inc Description and Business Overview
Table 113. Genentech Inc Asthma Medication Product
Table 114. Genentech Inc Recent Development
Table 115. Sepracor, Inc Corporation Information
Table 116. Sepracor, Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Sepracor, Inc Description and Business Overview
Table 118. Sepracor, Inc Asthma Medication Product
Table 119. Sepracor, Inc Recent Development
Table 120. Schering-Plough Corp Corporation Information
Table 121. Schering-Plough Corp Description and Business Overview
Table 122. Schering-Plough Corp Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Schering-Plough Corp Asthma Medication Product
Table 124. Schering-Plough Corp Recent Development
Table 125. Sanofi-Aventis Corporation Information
Table 126. Sanofi-Aventis Description and Business Overview
Table 127. Sanofi-Aventis Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Sanofi-Aventis Asthma Medication Product
Table 129. Sanofi-Aventis Recent Development
Table 130. Theravance Inc Corporation Information
Table 131. Theravance Inc Description and Business Overview
Table 132. Theravance Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Theravance Inc Asthma Medication Product
Table 134. Theravance Inc Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Asthma Medication Distributors List
Table 138. Asthma Medication Customers List
Table 139. Asthma Medication Market Key Trends
Table 140. Asthma Medication Key Opportunities and Drivers
Table 141. Asthma Medication Market Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Asthma Medication Product Picture
Figure 2. Global Asthma Medication Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Asthma Medication Market Share by Application in 2020 & 2026
Figure 6. Children Examples
Figure 7. Adolescent Examples
Figure 8. Adult Examples
Figure 9. Global Asthma Medication Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Asthma Medication Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Asthma Medication Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Asthma Medication Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Asthma Medication Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Asthma Medication Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Asthma Medication Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Asthma Medication Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Asthma Medication Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Asthma Medication Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Asthma Medication Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Asthma Medication Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Asthma Medication Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Asthma Medication Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Asthma Medication Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Asthma Medication Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Asthma Medication Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Asthma Medication Players Market Share by Revenue in Asthma Medication 2015 & 2019
Figure 27. Asthma Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Asthma Medication Revenue Share by Type (2015-2020)
Figure 29. Global Asthma Medication Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Asthma Medication Revenue Share by Application (2015-2020)
Figure 31. Global Asthma Medication Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Asthma Medication Sales Market Share by Type in 2019
Figure 33. United States Asthma Medication Sales Market Share by Type in 2019
Figure 34. Europe Asthma Medication Sales Market Share by Company in 2019
Figure 35. Europe Asthma Medication Sales Market Share by Type in 2019
Figure 36. Europe Asthma Medication Sales Market Share by Application in 2019
Figure 37. China Asthma Medication Sales Market Share by Company in 2019
Figure 38. China Asthma Medication Sales Market Share by Type in 2019
Figure 39. China Asthma Medication Sales Market Share by Application in 2019
Figure 40. Japan Asthma Medication Sales Market Share by Company in 2019
Figure 41. Japan Asthma Medication Sales Market Share by Type in 2019
Figure 42. Japan Asthma Medication Sales Market Share by Application in 2019
Figure 43. Southeast Asia Asthma Medication Sales Market Share by Company in 2019
Figure 44. Southeast Asia Asthma Medication Sales Market Share by Type in 2019
Figure 45. Southeast Asia Asthma Medication Sales Market Share by Application in 2019
Figure 46. India Asthma Medication Sales Market Share by Company in 2019
Figure 47. India Asthma Medication Sales Market Share by Type in 2019
Figure 48. India Asthma Medication Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Asthma Medication
Figure 51. Manufacturing Process Analysis of Asthma Medication
Figure 52. Asthma Medication Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
吸入薬用装置の世界市場レポート2020 Market Analysis and Insights: Global Devices for Inhaled Medications Market The global Devices for Inhaled Medications market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Devices for Inhaled Medications Scope and Market Siz…- 公共安全長期的進化デバイスの世界市場レポート2020 Market Analysis and Insights: Global Public Safety Long-Term Evolution Devices Market The global Public Safety Long-Term Evolution Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Public Safety Long-Term Evolutio…
- C5aアナフィラトキシン走化性受容体1の世界市場レポート2020 Market Analysis and Insights: Global C5a Anaphylatoxin Chemotactic Receptor 1 Market The global C5a Anaphylatoxin Chemotactic Receptor 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global C5a Anaphylatoxin Chemotactic Rece…
- アレルギー免疫療法の世界市場レポート2020 Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves…
- 爪真菌症（爪白癬）治療薬の世界市場レポート2020 Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate. Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease. USA is the largest consumption place, with a consumption market sh…